The Asia Pacific Microcrystalline Cellulose Market would witness market growth of 7.1% CAGR during the forecast period (2019-2025).
Microcrystalline cellulose manufacturers and research organizations around the globe have spent strongly in creating microcrystalline cellulose of high quality and low-priced. In addition, multiple methods such as reactive extrusion, steam explosion, enzyme, and acid hydrolysis, which are mediated to boost productivity, are being studied thoroughly.
The pharmaceutical industry is leading to excessive microcrystalline cellulose utilization. A further driver of the economy is the steady growth of pharmaceuticals in developed economies like Italy, Germany, and France. In most pharmaceutical formulations, its application as an excipient is a market propelling factor. The growing geriatric population, combined with other variables, requires a steady increase in pharmaceuticals, which in turn increases demand for microcrystalline cellulose.
Based on Source Type, the market is segmented into Wood Based and Non-Wood Based. Based on Application, the market is segmented into Pharmaceutical, Food & Beverage, Cosmetics & Personal Care and Other Application. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Rayonier Advanced Material, Inc., Accent Microcell Pvt. Ltd., JRS Pharma LP, Sigachi Industries Pvt Ltd., Huzhou Zhanwang Pharmaceutical Co., Ltd., Roquette Freres SA, Avantor Performance Materials, Inc., FMC Corporation, Asahi Kasei Corporation, and Mitsubishi Chemical Holdings Corporation.
Market Segmentation:
By Source Type
By Application
By Country
Companies Profiled
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 